$PFE Headlines Pfizer's Rapamune doesn't meet primary

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2013 at 1:26 PM

$PFE Headlines

Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com
The Next 24: Apple Angst, India Rate Hike 5:40 p.m. Oct. 28, 2013 - MarketWatch
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
At the NYSE, Larry Kofsky looks at the week ahead 7:01 a.m. Oct. 27, 2013 - MarketWatch
What Google and Netflix are telling us 12:37 p.m. Oct. 24, 2013 - Mark Hulbert

Pfizer And Merck Continue To Battle Declining Revenue 11:49 a.m. Today - Seeking Alpha
10-Q: PFIZER INC 3:45 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
Alcoa Backs London Metal Exchange Up to a Point and 2 Other Hot Stocks to Watch 1:44 p.m. Nov. 8, 2013 - Wall St. Cheat Sheet
107-Year Old Irving Kahn Buys BP, BlackBerry, New York Community Bancorp, Sells SLM, Seaboard, ... 10:30 a.m. Nov. 8, 2013 - GuruFocus.com
AbbVie's Not as Vulnerable as the Street Believes 6:30 a.m. Nov. 8, 2013 - TheStreet.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Irving Kahn's High-Impact Sells in Third Quarter 5:22 p.m. Nov. 7, 2013 - GuruFocus.com
Glycomimetics IPO Is Risky But Promising 8:20 p.m. Nov. 6, 2013 - Seeking Alpha
Wal-Mart Blames Tech Glitch for Temporary Weird Prices and 2 Other Dow Movers to Watch 1:38 p.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Nov. 6, 2013 - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Karyopharm Therapeutics IPO Looks Promising 7:44 a.m. Nov. 6, 2013 - Seeking Alpha
U.S. Launch of Actelion's Opsumit - Analyst Blog 4:30 p.m. Nov. 5, 2013 - Zacks.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Marginal Earnings Miss at Zoetis in Q3 - Analyst Blog 4:19 p.m. Nov. 5, 2013 - Zacks.com
FDA Okays Pfizer’s Embeda Extended Release Capsules and 2 Other Hot Stocks to Watch 2:10 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - CFN, PFE, IACI, GMED And TUP Traded By Insiders 12:16 p.m. Nov. 5, 2013 - TheStreet.com

Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
Critical Stock Analysis: Pfizer, Barrick Gold Corporation, Micron Technology, Wells Fargo, Zynga 8:50 a.m. Nov. 1, 2013 - PR Newswire
Pain Therapeutics Reports Q3 2013 Financial Results 8:00 a.m. Oct. 31, 2013 - GlobeNewswire
NLY, BAC, DDD and PFE added to NYSE Active Stock Watch List at GSR 9:28 a.m. Oct. 29, 2013 - ACCESSWIRE
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
Pfizer Reports Third-Quarter 2013 Results 7:00 a.m. Oct. 29, 2013 - BusinessWire
Positive Clinical Trial Results, Patient Enrollment, and Collaborations - Research Report on Pfizer, Medivation, AbbVie, Cigna, and AstraZeneca 9:00 a.m. Oct. 28, 2013 - PR Newswire
Nodality, Inc. Announces Presentations at 2013 American College of Rheumatology Annual Meeting 7:30 a.m. Oct. 28, 2013 - BusinessWire
Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk 6:00 a.m. Oct. 28, 2013 - BusinessWire
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend 4:00 p.m. Oct. 24, 2013 - BusinessWire
TherapeuticsMD Appoints Sebastian Mirkin, M.D. as Chief Medical Officer 7:57 a.m. Oct. 23, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Altitude+ and ViewLift Celebrate Record Fan Engagement

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

NJ's $21.3M Water Fix Fights PFAS, Boosts AWK

Water Woes Culminate in Triumph Alright, folks, you don't often see New Jersey in the headlines for anything groundbreaking in the right way, but here we are. The big news is a hefty $21.3 million project completion that finally puts some ammo against the notorious PFAS chemicals. If you've got any skin in the utility game or just a stake in clean water, this one's been...

CTCA Tackles Trust Issues in $B-illion Card Market

Gaps in a Booming Industry Trading cards might sound like kid stuff, but don’t be fooled—there's billions riding on paper and ink these days. Yet, a dark cloud hovers over the trading card scene, where questions of transparency and accountability loom large. Digital repacks and those dicey randomized packs have folks questioning what’s in the mix: Is it a safe bet...

Venezuelan Crude Hits Texas: NABEP's Bold Move

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Infotech's 2027 Trends: AI Reshapes Strategy & Risk

AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...

Red Robin Faces Board Shakeup and Financial Strategy Shift

Turbulence on the Board But Strategic Moves on Track Well, it's not every day you hear about a double departure from Red Robin's board, right on the heels of some big financial reshuffling. Two directors, James C. Pappas and Christopher Martin, decided to abandon ship effective October 23, 2026. Given their ties to JCP Investment and Jumana Capital, this isn't just a...

Latham & Harvey Boost Fund Formation With AI Tech

AI Joins Forces with Legal Expertise Latham & Watkins LLP and Harvey are teaming up to revolutionize how fund formation gets done. They're jumping into the AI waters with both feet, aiming to make the fund documentation process less of a nightmare and more of a breeze for lawyers. The idea isn't just to cut down on the grunt work, but to let attorneys zero in on what's...

Posterity Health Boosts Network to Six New Markets

Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...

Steel Vet Shift: John Pritchett Takes Helm at Trojan

Trojan Steel's Bold Move with John Pritchett at the Helm Trojan Steel is changing the game by appointing John C. Pritchett as its new President. This isn't just another shuffle of suits in the boardroom—it's a statement. Pritchett isn't some steel industry old-timer; instead, he's a business leader with a knack for scaling operations. With a resume that includes...

Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...